Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dezima Pharma
Biotech
NewAmsterdam bags $196M to resurrect Amgen's discarded CETP drug
The series A will support the revitalization of obicetrapib, part of the once-hyped CETP class of molecules that was torpedoed by clinical setbacks.
Nick Paul Taylor
Jan 14, 2021 8:35am
Forbion raises €270M, EU-focused life science fund
Jul 11, 2018 3:00am
Versant, Novartis power cystic fibrosis startup to B round
Apr 12, 2018 3:00am
Ex-Dezima execs scoop €25M for midphase NASH trial
Dec 12, 2017 7:50am
Bristol-Myers, Johnson & Johnson help BGV top fund goal
Oct 31, 2017 8:25am
Amgen kills off CETP inhibitor after seeing Merck data
Oct 26, 2017 8:45am
